Successful treatment of schizophrenia with melperone augmentation in a patient with phenotypic CYP2D6 ultrarapid metabolization: a case report

<p>Abstract</p> <p>Introduction</p> <p>There are limited treatment options for people with schizophrenia with cytochrome P450 2D6 ultrarapid metabolizer status who do not respond to amisulpride.</p> <p>Furthermore, the literature does not provide evidence-ba...

Full description

Bibliographic Details
Main Authors: Gahr Maximilian, Gastl Regina, Kölle Markus A, Schönfeldt-Lecuona Carlos, Freudenmann Roland W
Format: Article
Language:English
Published: BMC 2012-02-01
Series:Journal of Medical Case Reports
Online Access:http://www.jmedicalcasereports.com/content/6/1/49
_version_ 1818208942255243264
author Gahr Maximilian
Gastl Regina
Kölle Markus A
Schönfeldt-Lecuona Carlos
Freudenmann Roland W
author_facet Gahr Maximilian
Gastl Regina
Kölle Markus A
Schönfeldt-Lecuona Carlos
Freudenmann Roland W
author_sort Gahr Maximilian
collection DOAJ
description <p>Abstract</p> <p>Introduction</p> <p>There are limited treatment options for people with schizophrenia with cytochrome P450 2D6 ultrarapid metabolizer status who do not respond to amisulpride.</p> <p>Furthermore, the literature does not provide evidence-based guidelines for this particular constellation.</p> <p>Case presentation</p> <p>We report the case of a 50-year-old Caucasian female patient with schizophrenia and cytochrome P450 2D6 ultrarapid metabolizer status who experienced an insufficient antipsychotic effect with amisulpride. She was successfully treated with melperone-augmented haloperidol.</p> <p>Conclusion</p> <p>This report yields melperone-augmented haloperidol as a possible pharmacological strategy in the described situation. In addition, our observations support the available evidence for the potential of melperone to act as an inhibitor of cytochrome P450 2D6.</p>
first_indexed 2024-12-12T04:52:50Z
format Article
id doaj.art-14095c0d22b248919082dd008d7aa7ca
institution Directory Open Access Journal
issn 1752-1947
language English
last_indexed 2024-12-12T04:52:50Z
publishDate 2012-02-01
publisher BMC
record_format Article
series Journal of Medical Case Reports
spelling doaj.art-14095c0d22b248919082dd008d7aa7ca2022-12-22T00:37:25ZengBMCJournal of Medical Case Reports1752-19472012-02-01614910.1186/1752-1947-6-49Successful treatment of schizophrenia with melperone augmentation in a patient with phenotypic CYP2D6 ultrarapid metabolization: a case reportGahr MaximilianGastl ReginaKölle Markus ASchönfeldt-Lecuona CarlosFreudenmann Roland W<p>Abstract</p> <p>Introduction</p> <p>There are limited treatment options for people with schizophrenia with cytochrome P450 2D6 ultrarapid metabolizer status who do not respond to amisulpride.</p> <p>Furthermore, the literature does not provide evidence-based guidelines for this particular constellation.</p> <p>Case presentation</p> <p>We report the case of a 50-year-old Caucasian female patient with schizophrenia and cytochrome P450 2D6 ultrarapid metabolizer status who experienced an insufficient antipsychotic effect with amisulpride. She was successfully treated with melperone-augmented haloperidol.</p> <p>Conclusion</p> <p>This report yields melperone-augmented haloperidol as a possible pharmacological strategy in the described situation. In addition, our observations support the available evidence for the potential of melperone to act as an inhibitor of cytochrome P450 2D6.</p>http://www.jmedicalcasereports.com/content/6/1/49
spellingShingle Gahr Maximilian
Gastl Regina
Kölle Markus A
Schönfeldt-Lecuona Carlos
Freudenmann Roland W
Successful treatment of schizophrenia with melperone augmentation in a patient with phenotypic CYP2D6 ultrarapid metabolization: a case report
Journal of Medical Case Reports
title Successful treatment of schizophrenia with melperone augmentation in a patient with phenotypic CYP2D6 ultrarapid metabolization: a case report
title_full Successful treatment of schizophrenia with melperone augmentation in a patient with phenotypic CYP2D6 ultrarapid metabolization: a case report
title_fullStr Successful treatment of schizophrenia with melperone augmentation in a patient with phenotypic CYP2D6 ultrarapid metabolization: a case report
title_full_unstemmed Successful treatment of schizophrenia with melperone augmentation in a patient with phenotypic CYP2D6 ultrarapid metabolization: a case report
title_short Successful treatment of schizophrenia with melperone augmentation in a patient with phenotypic CYP2D6 ultrarapid metabolization: a case report
title_sort successful treatment of schizophrenia with melperone augmentation in a patient with phenotypic cyp2d6 ultrarapid metabolization a case report
url http://www.jmedicalcasereports.com/content/6/1/49
work_keys_str_mv AT gahrmaximilian successfultreatmentofschizophreniawithmelperoneaugmentationinapatientwithphenotypiccyp2d6ultrarapidmetabolizationacasereport
AT gastlregina successfultreatmentofschizophreniawithmelperoneaugmentationinapatientwithphenotypiccyp2d6ultrarapidmetabolizationacasereport
AT kollemarkusa successfultreatmentofschizophreniawithmelperoneaugmentationinapatientwithphenotypiccyp2d6ultrarapidmetabolizationacasereport
AT schonfeldtlecuonacarlos successfultreatmentofschizophreniawithmelperoneaugmentationinapatientwithphenotypiccyp2d6ultrarapidmetabolizationacasereport
AT freudenmannrolandw successfultreatmentofschizophreniawithmelperoneaugmentationinapatientwithphenotypiccyp2d6ultrarapidmetabolizationacasereport